Identification of allergen-resolved threshold doses of carrot (Daucus carota) by means of oral challenge and ELISA - 30/05/13
Doi : 10.1016/j.jaci.2012.12.1577
Kay Foetisch, PhD a, ∗ 
, Stephan Scheurer, PhD a, Stefan Vieths, PhD a, Kay-Martin Hanschmann, MSc b, Jonas Lidholm, PhD c, Vera Mahler, MD d, ∗
, Stephan Scheurer, PhD a, Stefan Vieths, PhD a, Kay-Martin Hanschmann, MSc b, Jonas Lidholm, PhD c, Vera Mahler, MD d, ∗ a Division of Allergology, Paul-Ehrlich Institut, Langen, Germany
b Division of Microbiology, Biostatistics Section, Paul-Ehrlich Institut, Langen, Germany
c Thermo Fisher Scientific, Uppsala, Sweden
d Department of Dermatology, University Hospital, Erlangen, Germany
| This study was supported by the German Research foundation (DFG VI 165/6-1 and DFG MA1997/3-1). |
|
| Disclosure of potential conflict of interest: K. Foetisch has been supported by one or more grants from the German Research Foundation (DFG VI 165/6-1). S. Scheurer has been supported by one or more grants from the German Research Foundation (DFG VI 165/6-1). J. Lidholm is employed by Thermo Fisher Scientific. V. Mahler has been supported by one or more grants from the German Research Foundation (DFG MA1997/3-1). S. Vieths has consultant arrangements with the Food Allergy Resource and Research Program, the Institute for Product Quality, and Fresenius Academy; is employed by Johann Wolfgang Goethe-Universität; has provided expert testimony for the Medical University of Vienna; has received grants from the Monsanto Company and Pioneer Hi-Bred International; has received payment for lectures from Deutsche Dermatologische Gesellschaft, the Spanish Society of Allergy and Clinical Immunology, Westdeutsche Arbeitsgemeinschaft fur Pädiatrische Pneumologie and Allergologie e.V., Gesellschaft für Pädiatrische Allergologie und Umweltmedizin, and the American Academy of Asthma, Allergy & Immunology; has received royalties from Schattauer Allergologie Handbuch and Elsevier Nahrungsmittelallergie und Intoleranzen; and has received travel expenses from the German Research Foundation, the Federal Institute for Risk Assessment, the Austrian Society for Allergology and Immunology, the French Society of Allergology, the European Directorate for the Quality of Medicines and Health Care, the European Academy of Allergy and Clinical Immunology, the World Allergy Organization, Technical University of Munich, Deutscher Allergie und Asthmabund, Association Monégasque pour le Perfectionnement des Connaissances des Médicins, the Federal Office of Consumer Protection and Food Safety, the German Chemical Society, the Austrian Society for Dermatology and Venerology, and AKM Allergiekongress. K.-M. Hanschmann declares that she has no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 6
P. 1711 - juin 2013 Retour au numéro
Article précédent
- Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations
- Andras Bors, Dorottya Csuka, Lilian Varga, Henriette Farkas, Attila Tordai, George Füst, Agnes Szilagyi
- Serum tryptase determination in patients with acute allergic reactions
- Joana Vitte, Pierre Bongrand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?